Literature DB >> 6090882

Kinetic differences between type I and type II benzodiazepine receptors.

R R Trifiletti, M M Lo, S H Snyder.   

Abstract

The kinetic properties of [3H]flunitrazepam [( 3H]FNZ) binding to central benzodiazepine receptors of bovine brain membranes at 0 degrees have been studied. Both dissociation and association (under pseudo-first order conditions) kinetics are biphasic, enabling definition of "fast" and "slow" compartments for both processes. In four brain regions examined, the proportion of receptor in the rapidly associating and rapidly dissociating compartments correlates with the proportion of Type I benzodiazepine receptor as determined from equilibrium radioligand binding studies in the four brain regions examined. Preincubation with the Type I-selective drugs CL-218,872 or methyl-beta-carboline-3-carboxylate (Ro 22-7497) reduces the size of the fast but not the slow kinetic compartments. Potencies of the drugs in eliciting these alterations in [3H]FNZ kinetics correlate with their potencies in displacing [3H]FNZ from Type I benzodiazepine receptors. Thus, in membrane preparations the more rapidly associating and dissociating site appears to represent the pharmacologically defined Type I benzodiazepine receptor, whereas the Type II receptors display slower association and dissociation kinetics. Soluble Type I receptors also display more rapid dissociation and association kinetics than soluble Type II receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090882

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  2 in total

1.  Modulation of the smooth-muscle L-type Ca2+ channel alpha1 subunit (alpha1C-b) by the beta2a subunit: a peptide which inhibits binding of beta to the I-II linker of alpha1 induces functional uncoupling.

Authors:  A Hohaus; M Poteser; C Romanin; N Klugbauer; F Hofmann; I Morano; H Haase; K Groschner
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 2.  Overview--flavonoids: a new family of benzodiazepine receptor ligands.

Authors:  J H Medina; H Viola; C Wolfman; M Marder; C Wasowski; D Calvo; A C Paladini
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.